Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system

BACKGROUND: In treatment-refractory liver dominant metastatic colorectal cancer, the role of liver directed therapies still is unclear. We sought to determine a prognostic score for Y90 radioembolization in these patients. METHODS: We analyzed 106 patients with refractory liver dominant mCRC who had...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Damm, Robert, Seidensticker, Ricarda, Ulrich, Gerhard, Breier, Leonie, Steffen, Ingo G., Seidensticker, Max, Garlipp, Benjamin, Mohnike, Konrad, Pech, Maciej, Amthauer, Holger, Ricke, Jens
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2016
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4955133/
https://ncbi.nlm.nih.gov/pubmed/27439702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2549-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi